| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), RAPT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| Dir | 0 | - | - | |
| Other | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2019 | Topspin Fund L.P. | 10% Owner | Buy | 415,000 | $12.00 | $4,980,000.00 | +19.2% | |
| Nov 4, 2019 | Robbins Wendye59 | Director | Buy | 1,600 | $12.00 | $19,200.00 | New | |
| Nov 4, 2019 | Column Group Ii, LP83 | 10% Owner | Buy | 625,000 | $12.00 | $7,500,000.00 | +14.3% |